Hair lead and cadmium concentrations in patients with epilepsy and migraine

Neuroscience Research Communications

Volumn 32, Issue 2, 2003, Pages 107-114

  Sasmaz, Sezai ^a   Uz, Efkan ^b   Pinar, Tevfik ^c   Vural, Hüseyin ^d   Eiri, Mücahit ^e   Ilhan, Atilla ^e   Akyol, Ömer ^e,f  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d HARRAN UNIVERSITY   (Turkey)

^e INONU UNIVERSITY   (Turkey)

^f INONU UNIVERSITY   (Turkey)

Author keywords

Cadmium; Epilepsy; Hair; Lead; Migraine; Neurocutaneous disorders

Indexed keywords

CADMIUM; LEAD; TRACE ELEMENT;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BRAIN LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PATHOPHYSIOLOGY; SCALP HAIR; SEIZURE;

EID: 0038555679     PISSN: 08936609     EISSN: None     Source Type: Journal    
DOI: 10.1002/nrc.10065     Document Type: Article

References (27)

1. Rice D, Barone S. Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models. Environ Health Perspect 2000;108:511-533 (Suppl).
2. Porter WH, Moyer TP. Clinical Toxicology. In Tietz Fundamentals of Clinical Chemistry (Burtis, C.A., Ashwood, E.R., Aldrich J.E., Eds.), W. B. Saunders Company Philadelphia, 1996. p 451-453.
3. Hotzman D, Herman MM, Hsu JS, Mortell P. The pathogenesis of lead encephalopathy. Virchows Arch A Pathol Anat Histol 1980;387:147-164.
4. Sildberg EK, Adler HS. Subcellular mechanisms of lead neurotoxicity. Brain Res 1978;148:451-467.
5. Bagchi D, Vuchetich M, Bagchi M, Hassoun EA, Tran MX, Tang L, Stohs SJ. Induction of oxidative stress by chronic administration of sodium dichromate [chromium VI] and cadmium chloride [cadmium II] to rats. Free Radic Biol Med 1997;22:471-478.
6. Zelikoff JT, Bowser D, Squibb KS, Frenkel K. Immunotoxicity of low level cadmium exposure in fish: Alternative animal models for immunotoxicological studies. J Toxicol Environ Health 1995;45:235-248.
7. Conologue T, Meffert J. Dermatologic manifestations of neurologic disease. Last updated November 4, 2002. www.emedicine.com/derm/topic549.htm
8. Garvey MJ, Tollefson GD. Association of affective disorder with migraine headaches and neurodermatitis. Gen Hosp Psychiatry 1988;10:148-9.
9. Tietjen GE, Al-Qasmi MM, Shukairy MS. Livedo reticularis and migraine a marker for stroke risk? Headache 2002;42:352-5.
10. Ilhan A, Uz E, Kali S, Var A, Akyol O. Serum and hair trace element levels in patients with epilepsy and healthy subjects: does the antiepileptic therapy affect the element concentrations of hair. Eur J Neurol 1999;6:705-709.
11. Ilhan A, Uz E, Var A, Kali S, Akyol O. Diagnostic role of hair magnesium in migraine patients: higher than serum magnesium? Trace Elem Electroly 2000;17:14-18.
12. Akyol O, Ersan F, Akcay F, Altuntas I, Senol M, Sasmaz S, Yasar A. Hair, nail, serum and urine copper levels in users of copper intrauterine devices and interactions between copper and some other trace elements. Trace Elem Electroly 1997;14:124-129.
13. Kirgbright GF. Atomic absorbtion spectroscopy. In: Elemental Analysis of Biological Materials. Vienna Technical Report Series, International Atomic Energy Agency; 1980;197:141-165.
14. McCarren M, Young GA, Eccles CU. Spectral analysis of kindled hippocampal after discharges in lead-treated rats. Epilepsia 1984;25:53-60.
15. Bittigau P, Ikonomidou C. Glutamate in neurologic diseases. J Child Neurol 1997;12:471-485.
16. Savolainen KM, Loikkanen J, Eerikainen S, Naarala J. Interactions of exitatory neurotransmitters and xenobiotics in excitotoxicity and oxidative stress: glutamate and lead. Toxicol Lett 1998;102-103:363-367.
17. Oberto A, Marks N, Evans HL, Guidotti A. Lead (Pb+2) promotes apoptosis in newborn rat cerebellar neurons: pathological implications. J Pharmacol Exp Ther 1996;279:435-442.
18. Savolainen KM, Loikkanen J, Eerikainen S, Naarala J. Glutamate-stimulated reactive oxygen species (ROS) production in neuronal cultures: interactions with lead and the cholinergic system. Neurotoxicology 1998;19:669-674.
19. Loikkanen JJ, Naarala J, Savolainen KM. Modification of glutamate-induced oxidative stress by lead: the role of extracellular calcium. Free Radic Biol Med 1998;24:377-384.
20. Yi EY, Lim DK. Effects of chronic led exposure on glutamate release and uptake in cerebellar cells of rat pups. Arch Pharm Res 1998;21:113-119.
21. Sevlever G, Taratuto A, Martinetto H, D'Giano C, Schultz M, Pomata H, Rabinowicz A. Metallothionein gene expression and chemoresistance markers in temporal lobe epilepsy. J Neuropathol Exp Neurol 2001;60:194.
22. Larrson B, Tjalve H. Studies on the mechanism of drug-binding to melanin. Biochem Pharmacol 1979;28:1181-1187.
23. Larrson BS. Interaction between chemicals and melanin. Pigment Cell Res 1993;6:127-133.
24. Lyden A, Larsson BS, Lindquist NG. Melanin affinity of manganese. Acta Pharmacol Toxicol 1984;55:133-138.
25. rd Annual Meeting of the ESPCR, Amsterdam, 1991. p 62.
26. Marcus S. Toxycity, lead. Last Updated: June 4, 2001. www.emedicine.com/emerg/topic293.htm
27. Karabiber H, Sasmaz S, Turanl G, Yak nc C. Prevalence of hypopigmented maculae and caféau-lait spots in idiopathic epileptic and healthy children. J Child Neurol 2002;17:57-59.